Open Competition M2 grant for immunoglobulin analysis for Andrea Gargano

Dr. Andrea Gargano receive together with Dr. Elena Dominguez Vega of the Leiden University Medical Center € 740,000 for their four-year HYPE-IMMUNe research project involving two PhD students.
Facebook
Twitter
Pinterest
LinkedIn

Dr. Andrea Gargano of the research group Analytical Chemistry together with Dr. Elena Dominguez Vega of the Center for Proteomics and Metabolomics at Leiden University Medical Center have been awarded an NWO Open Competition M2-grant. Together they receive about € 740,000 for their four-year HYPE-IMMUNe research project involving two PhD students.

The HYPE-IMMUNe project focuses on developing methods to characterize the structures and function of serum immunoglobulins, which are among the most important molecules of the immune system and exist in myriads of different variants. The projects will focus on the development of separation and affinity workflows coupled with mass spectrometry to disclose the structure-function relationship of the immunoglobulins responsible for the response to a disease or an autoimmune response. This technology will open new frontiers in advancing novel biotherapeutics and early disease diagnostics.

The M-grants issued by the Domain Board Science of the Dutch Research Council NWO are intended for innovative, high-quality, fundamental research and/or studies involving matters of scientific urgency. They offer researchers the possibility to elaborate creative and risky ideas and to realise scientific innovations that can form the basis for the research themes of the future. In the current round of the Open Competition Domain Science-M programme, eighteen grant applications were approved out of 72 applications.

Further Reading

Related Posts

Novel sequencing approach enables detailed characterization of PLGA co-polymers

CAST Scientst Masashi Serizawas was published in Macromolecules. Masashi presents a ‘polymer sequencing’ approach for analyzing the composition of PLGA copolymers in great detail. The method consists of controlled chemical degradation followed by reversed-phase liquid chromatography and high-resolution mass spectrometry (RPLC-HRMS) to arrive at an accurate characterisation of block-length distribution. The work provides a robust framework for the rational design of sequence-controlled PLGA for drug delivery and other advanced applications.

Microscale native SEC-HRMS to characterize immunoconjugates

In this study, CAST scientists Annika van der Zon et al., in collaboration with Bram Weijers and Danielle Vlugts (Amsterdam UMC), introduce a rapid, microscale aqueous size-exclusion chromatography–mass spectrometry (SEC-MS) method to measure chelator to antibody ratio in immunoconjugates.

Bob Pirok receives LCGC Emerging Leader award

Bob Pirok has been named winner of the 2026 LCGC International Emerging Leader in Chromatography Award, recognizing his contributions to automated method development, LC×LC, chemometrics, and artificial intelligence in separation science.